Aspire BioPharma has raised capital from its founders, key executives, family and friends, accredited investors and is now planning to supplement its capital raise via crowdfunding.
We are pleased to announce that we have selected Republic.com to launch a Regulation Crowdfunding Campaign to give small investors a chance to participate in supporting our company and having an ownership stake in our disruptive technology.
We have also engaged Republic.com to launch a Regulation D offering for accredited investors that would like to invest and become part of our grow story.
We have officially launched our capital raise via Republic.com for accredited and unaccredited investors. Click HERE to become an owner of Aspire BioPharma Inc.
You may email us or call us if you require more information on our technology, financial projections, patent filing and strategy.